Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 5
2005 2
2006 2
2008 5
2009 4
2010 5
2011 4
2012 5
2013 3
2014 7
2015 7
2016 7
2017 10
2018 6
2019 10
2020 13
2021 14
2022 9
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Leonetti A, Perrone F, Puntoni M, Maglietta G, Bordi P, Bria E, Vita E, Gelsomino F, De Giglio A, Gelibter A, Siringo M, Mazzoni F, Caliman E, Genova C, Bertolini F, Guaitoli G, Passiglia F, Delcuratolo MD, Montrone M, Cerea G, Pasello G, Roca E, Belluomini L, Cecere FL, Guida A, Manzo A, Adamo V, Rastelli F, Bulotta A, Citarella F, Toschi L, Zoratto F, Cortinovis DL, Berardi R, Follador A, Carta A, Camerini A, Salerno F, Silva RR, Baldini E, Cortellini A, Brighenti M, Santoni M, Malorgio F, Caminiti C, Tiseo M. Leonetti A, et al. Among authors: adamo v. Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11. Eur J Cancer. 2024. PMID: 38489861
Stereotactic boost on residual disease after external-beam irradiation in clinical stage III non-small cell lung cancer: mature results of stereotactic body radiation therapy post radiation therapy (SBRTpostRT) study.
Parisi S, Ferini G, Lillo S, Brogna A, Chillari F, Ferrantelli G, Settineri N, Santacaterina A, Platania A, Leotta S, Casablanca G, Russo A, Pontoriero A, Adamo V, Minutoli F, Bottari A, Cacciola A, Pergolizzi S. Parisi S, et al. Among authors: adamo v. Radiol Med. 2023 Jul;128(7):877-885. doi: 10.1007/s11547-023-01659-w. Epub 2023 Jun 9. Radiol Med. 2023. PMID: 37294366
Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study.
Normanno N, De Luca A, Abate RE, Morabito A, Milella M, Tabbò F, Curigliano G, Masini C, Marchetti P, Pruneri G, Guarneri V, Frassineti GL, Fasola G, Adamo V, Daniele B, Berardi R, Feroce F, Maiello E, Pinto C. Normanno N, et al. Among authors: adamo v. Eur J Cancer. 2023 Jul;187:174-184. doi: 10.1016/j.ejca.2023.03.027. Epub 2023 Mar 30. Eur J Cancer. 2023. PMID: 37167765 Free article.
Minimally invasive approach to incisional hernia in elective and emergency surgery: a SICE (Italian Society of Endoscopic Surgery and new technologies) and ISHAWS (Italian Society of Hernia and Abdominal Wall Surgery) online survey.
Crepaz L, Sartori A, Podda M, Ortenzi M, Di Leo A, Stabilini C, Carlucci M, Olmi S; SICE/ISHAWS collaborative group. Crepaz L, et al. Updates Surg. 2023 Sep;75(6):1671-1680. doi: 10.1007/s13304-023-01505-8. Epub 2023 Apr 18. Updates Surg. 2023. PMID: 37069372
Endoscopic fluorescent lymphography for gastric cancer.
Calcara C, Cocciolillo S, Marten Canavesio Y, Adamo V, Carenzi S, Lucci DI, Premoli A. Calcara C, et al. Among authors: adamo v. World J Gastrointest Endosc. 2023 Feb 16;15(2):32-43. doi: 10.4253/wjge.v15.i2.32. World J Gastrointest Endosc. 2023. PMID: 36925646 Free PMC article. Review.
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.
Puliafito I, Chillari F, Russo A, Cantale O, Sciacca D, Castorina L, Colarossi C, Franchina T, Vitale MP, Ricciardi GRR, Adamo V, Esposito F, Giuffrida D. Puliafito I, et al. Among authors: adamo v. Front Endocrinol (Lausanne). 2023 Jan 30;14:1065599. doi: 10.3389/fendo.2023.1065599. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36793289 Free PMC article.
Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer.
de Miguel-Perez D, Russo A, Gunasekaran M, Buemi F, Hester L, Fan X, Carter-Cooper BA, Lapidus RG, Peleg A, Arroyo-Hernández M, Cardona AF, Naing A, Hirsch FR, Mack PC, Kaushal S, Serrano MJ, Adamo V, Arrieta O, Rolfo C. de Miguel-Perez D, et al. Among authors: adamo v. Cancer. 2023 Feb 15;129(4):521-530. doi: 10.1002/cncr.34576. Epub 2022 Dec 9. Cancer. 2023. PMID: 36484171 Free article.
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®).
Caminiti C, Bryce J, Riva S, Ng D, Diodati F, Iezzi E, Sparavigna L, Novello S, Porta C, Del Mastro L, Procopio G, Cinieri S, Falzetta A, Calabrò F, Lorusso V, Cogoni AA, Tortora G, Maruzzo M, Passalacqua R, Cognetti F, Adamo V, Capelletto E, Ferrari A, Bagnalasta M, Bassi M, Nicelli A, De Persis D, D'Acunti A, Iannelli Patient E, Perrone F, Mitchell SA. Caminiti C, et al. Among authors: adamo v. Tumori. 2023 Jun;109(3):324-334. doi: 10.1177/03008916221099558. Epub 2022 Jun 8. Tumori. 2023. PMID: 35674125 Free PMC article.
119 results